4,373
Participants
Start Date
May 31, 2001
Primary Completion Date
January 31, 2005
Study Completion Date
January 31, 2005
Pioglitazone
Pioglitazone 15 mg to 45 mg, tablets, orally, once daily for up to 48 months.
Placebo
Pioglitazone placebo-matching tablets, orally, once daily for up to 48 months
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Takeda
INDUSTRY